Fair Value (Tables)

9 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs:

Contingent Consideration Liability	Fair Value			Valuation Technique	Unobservable Inputs	Range	Selected
Revenue and EBITDA Based Payments	$	31.8	million	Discounted Cash Flow	Revenue Discount Rate	4% to 6%	5	%
					EBITDA Volatility	30% to 52.5%	50	%
					Revenue Volatility	5% to 7%	7	%

Fair Value Measurements, Recurring, Valuation Techniques

The following methods and assumptions were used to measure fair value:

Financial Instrument	Level	Valuation Technique/Inputs Used
Cash Equivalents: Money market funds	1	Market - Quoted market prices
Available-for-sale securities: Secondary market certificates of deposit	2	Market - Based on market data which use evaluated pricing models and incorporate available trade, bid, and other market information.
Trading securities: Mutual funds held in nonqualified SERP	1	Market - Quoted market prices
Derivative Assets: Stock warrants	3	Market - The privately-held company is in a start-up phase. The pricing of recent purchases or sales of the investment are considered, if any, as well as positive and negative qualitative evidence, in the assessment of fair value. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities.
Contingent earn-out liability	3	Income - Based on a valuation model that measures the present value of the probable cash payments based upon the forecasted operating performance of the acquisition and a discount rate that captures the risk associated with the liability.

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

As of March 31, 2021 and June 30, 2020, the fair values of financial assets that are measured at fair value on a recurring basis using the market or income approach are categorized as follows:

	March 31, 2021
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents: Money market funds	$	27,409	$	—	$	—	$	27,409
Available-for-sale securities: Secondary market certificates of deposit	—		501		—		501
Trading Securities: Mutual funds in nonqualified SERP	13,586		—		—		13,586
Derivatives: Stock warrants	—		—		1,500		1,500
Total assets at fair value	$	40,995	$	501	$	1,500	$	42,996
Liabilities
Contingent earn-out liability	—		—		31,790		31,790
Total liabilities at fair value	$	—	$	—	$	31,790	$	31,790
	June 30, 2020
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents: Money market funds	$	91,035	$	—	$	—	$	91,035
Available-for-sale securities: Secondary market certificates of deposit	—		5,294		—		5,294
Trading Securities: Mutual funds in nonqualified SERP	11,975		—		—		11,975
Derivatives: Stock warrants	—		—		1,500		1,500
Total assets at fair value	$	103,010	$	5,294	$	1,500	$	109,804

Non-recurring Fair Value Adjustment Technique

Non-recurring Fair Value Adjustment	Level	Valuation Technique/Inputs Used
Impairment of Right of Use Lease Assets and Related Asset Groups	3	Income - Based on a valuation model that measures the present value of remaining lease payments less estimated sublease income at a discount rate that captures the risk associated with the future cash flows.

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

Financial instruments that are not reflected in the Condensed Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following:

Financial Instrument	Level	Valuation Technique/Inputs Used
Notes receivable	2	Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer’s non-performance risk.
Equity securities without readily determinable fair value	3	Cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively.